What You Need to Know About the Buprenorphine Waiver

August 18th, 2016

The Substance Abuse and Mental Health Services Administration (SAMHSA) has released the Buprenorphine Waiver Notification Form for physicians who are eligible to increase their patient limits to 275 under new federal regulations. The link below provides access to an informational webinar, slide deck, the new Waiver Notification Form and provides clarification of the new rule.

Learn More

Posted in Content


A Project of the Governor's Institute on Alcohol & Substance Abuse and the North Carolina Society of Addiction Medicine.
Funded wholly or in part by the federal Substance Abuse Prevention and Treatment Block Grant Fund (CFDA #93.959) as a project of the NC Division of Mental Health, Developmental Disabilities & Substance Abuse Services.